USE OF IAP INHIBITORS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA.

摘要

The present invention relates to methods of treating hematological malignancies, including acute myeloid leukemia (AML), comprising the use of compounds that inhibit the binding of the Smac protein to IAPs ("IAP inhibitor"). The present invention also relates to the use of IAP inhibitors for the preparation of a medicament to treat hematological malignancies, including AML..